AI-generated summary
The authors report a randomized, double-blind trial of 102 patients with non-seasonal major depression who all took sertraline and were assigned to either bright white light or dim red light for 5 weeks. Score changes on three self-report scales were greatest in the bright light group, with a statistically significant difference only on the SCL-90R. The authors conclude the results support bright light as an adjunct treatment.
- Participants
- 102
- Who or what was studied
- Patients with non-seasonal major depression receiving sertraline
- Limits stated in the abstract
- Only one of three self-report scales reached statistical significance, and the abstract relies on patient-reported measures rather than clinician-rated outcomes.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on onlinelibrary.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Depression, Statistical significance, Bright light therapy. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.